Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Unlike cisplatin, which forms bifunctional DNA adducts, monofunctional platinum(II) complexes bind only one strand of DNA and might target cancer without causing auditory side-effects associated with cisplatin treatment. We synthesized the monofunctional triamine-ligated platinum(II) complexes, Pt(d...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5841658?pdf=render |
| _version_ | 1819163673738870784 |
|---|---|
| author | Jerry D Monroe Heidi L Hruska Hannah K Ruggles Kevin M Williams Michael E Smith |
| author_facet | Jerry D Monroe Heidi L Hruska Hannah K Ruggles Kevin M Williams Michael E Smith |
| author_sort | Jerry D Monroe |
| collection | DOAJ |
| description | Unlike cisplatin, which forms bifunctional DNA adducts, monofunctional platinum(II) complexes bind only one strand of DNA and might target cancer without causing auditory side-effects associated with cisplatin treatment. We synthesized the monofunctional triamine-ligated platinum(II) complexes, Pt(diethylenetriamine)Cl, [Pt(dien)Cl]+, and Pt(N,N-diethyldiethylenetriamine)Cl, [Pt(Et2dien)Cl]+, and the monofunctional heterocyclic-ligated platinum(II) complexes, pyriplatin and phenanthriplatin, and compared their 5'-GMP binding rates, cellular compartmental distribution and cellular viability effects. A zebrafish inner ear model was used to determine if the monofunctional complexes and cisplatin caused hearing threshold shifts and reduced auditory hair cell density. The four monofunctional complexes had varied relative GMP binding rates, but similar cytosolic and nuclear compartmental uptake in three cancer cell lines (A549, Caco2, HTB16) and a control cell line (IMR90). Phenanthriplatin had the strongest effect against cellular viability, comparable to cisplatin, followed by [Pt(Et2dien)Cl]+, pyriplatin and [Pt(dien)Cl]+. Phenanthriplatin also produced the highest hearing threshold shifts followed by [Pt(dien)Cl]+, [Pt(Et2dien)Cl]+, cisplatin and pyriplatin. Hair cell counts taken from four regions of the zebrafish saccule showed that cisplatin significantly reduced hair cell density in three regions and phenanthriplatin in only one region, with the other complexes having no significant effect. Utricular hair cell density was not reduced by any of the compounds. Our results suggest that placing greater steric hindrance cis to one side of the platinum coordinating center in monofunctional complexes promotes efficient targeting of the nuclear compartment and guanosine residues, and may be responsible for reducing cancer cell viability. Also, the monofunctional compounds caused hearing threshold shifts with minimal effect on hair cell density, which suggests that they may affect different pathways than cisplatin. |
| first_indexed | 2024-12-22T17:47:52Z |
| format | Article |
| id | doaj.art-2892b6c685c043dca707f59109576672 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T17:47:52Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2892b6c685c043dca707f591095766722022-12-21T18:18:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01133e019250510.1371/journal.pone.0192505Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.Jerry D MonroeHeidi L HruskaHannah K RugglesKevin M WilliamsMichael E SmithUnlike cisplatin, which forms bifunctional DNA adducts, monofunctional platinum(II) complexes bind only one strand of DNA and might target cancer without causing auditory side-effects associated with cisplatin treatment. We synthesized the monofunctional triamine-ligated platinum(II) complexes, Pt(diethylenetriamine)Cl, [Pt(dien)Cl]+, and Pt(N,N-diethyldiethylenetriamine)Cl, [Pt(Et2dien)Cl]+, and the monofunctional heterocyclic-ligated platinum(II) complexes, pyriplatin and phenanthriplatin, and compared their 5'-GMP binding rates, cellular compartmental distribution and cellular viability effects. A zebrafish inner ear model was used to determine if the monofunctional complexes and cisplatin caused hearing threshold shifts and reduced auditory hair cell density. The four monofunctional complexes had varied relative GMP binding rates, but similar cytosolic and nuclear compartmental uptake in three cancer cell lines (A549, Caco2, HTB16) and a control cell line (IMR90). Phenanthriplatin had the strongest effect against cellular viability, comparable to cisplatin, followed by [Pt(Et2dien)Cl]+, pyriplatin and [Pt(dien)Cl]+. Phenanthriplatin also produced the highest hearing threshold shifts followed by [Pt(dien)Cl]+, [Pt(Et2dien)Cl]+, cisplatin and pyriplatin. Hair cell counts taken from four regions of the zebrafish saccule showed that cisplatin significantly reduced hair cell density in three regions and phenanthriplatin in only one region, with the other complexes having no significant effect. Utricular hair cell density was not reduced by any of the compounds. Our results suggest that placing greater steric hindrance cis to one side of the platinum coordinating center in monofunctional complexes promotes efficient targeting of the nuclear compartment and guanosine residues, and may be responsible for reducing cancer cell viability. Also, the monofunctional compounds caused hearing threshold shifts with minimal effect on hair cell density, which suggests that they may affect different pathways than cisplatin.http://europepmc.org/articles/PMC5841658?pdf=render |
| spellingShingle | Jerry D Monroe Heidi L Hruska Hannah K Ruggles Kevin M Williams Michael E Smith Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. PLoS ONE |
| title | Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. |
| title_full | Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. |
| title_fullStr | Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. |
| title_full_unstemmed | Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. |
| title_short | Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand. |
| title_sort | anti cancer characteristics and ototoxicity of platinum ii amine complexes with only one leaving ligand |
| url | http://europepmc.org/articles/PMC5841658?pdf=render |
| work_keys_str_mv | AT jerrydmonroe anticancercharacteristicsandototoxicityofplatinumiiaminecomplexeswithonlyoneleavingligand AT heidilhruska anticancercharacteristicsandototoxicityofplatinumiiaminecomplexeswithonlyoneleavingligand AT hannahkruggles anticancercharacteristicsandototoxicityofplatinumiiaminecomplexeswithonlyoneleavingligand AT kevinmwilliams anticancercharacteristicsandototoxicityofplatinumiiaminecomplexeswithonlyoneleavingligand AT michaelesmith anticancercharacteristicsandototoxicityofplatinumiiaminecomplexeswithonlyoneleavingligand |